期刊
ACS SENSORS
卷 6, 期 3, 页码 1086-1093出版社
AMER CHEMICAL SOC
DOI: 10.1021/acssensors.0c02365
关键词
COVID-19; diagnosis; CRISPR; detection; nanoparticle
资金
- National Natural Science Foundation of China [91859123, 91959128]
- National Science and Technology Major Project of China [2018ZX10734401-009]
The outbreak of COVID-19 led to a global public health crisis, and large-scale population screening is an effective means to control its spread. Scientists have developed a magnetic pull-down-assisted colorimetric method based on the CRISPR/Cas12a system (M-CDC) for rapid and accurate detection of SARS-CoV-2, without the need for expensive instruments.
The outbreak of COVID-19 caused a worldwide public health crisis. Large-scale population screening is an effective means to control the spread of COVID-19. Reverse transcription-polymerase chain reaction (RT-qPCR) and serology assays are the most available techniques for SARS-CoV-2 detection; however, they suffer from either less sensitivity and accuracy or low instrument accessibility for screening. To balance the sensitivity, specificity, and test availability, here, we developed enhanced colorimetry, which is termed as a magnetic pull-down-assisted colorimetric method based on the CRISPR/Cas12a system (M-CDC), for SARS-CoV-2 detection. By this method, SARS-CoV-2 RNA from synthetic sequences and cultured viruses can be detected by the naked eye based on gold nanoparticle (AuNP) probes, with a detection limit of 50 RNA copies per reaction. With CRISPR/Cas12a-assisted detection, SARS-CoV-2 can be specifically distinguished from other closely related viruses. M-CDC was further used to analyze 41 clinical samples, whose performance was 95.12%, consistent with that of an approved Clinical RT-qPCR Diagnosis kit. The developed M-CDC method is not dependent on sophisticated instruments, which makes it potentially valuable to be applied for SARS-CoV-2 screening under poor conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据